Gender Differences in Self-Reported Symptom Awareness and Perceived Ability to Manage Therapy with Disease-Modifying Medication Among Commercially Insured Multiple Sclerosis Patients

BACKGROUND: Multiple sclerosis (MS) is a chronic, neurodegenerative inflammatory disease that affects approximately 400,000 Americans, the majority of whom are female. Although MS prevalence is higher among females, males are more likely to have a more progressive clinical course. For both genders,...

Descripción completa

Detalles Bibliográficos
Autores principales: Vlahiotis, Anna, Sedjo, Rebecca, Cox, Emily R., Burroughs, Thomas E., Rauchway, Amy, Lich, Rebecca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438194/
https://www.ncbi.nlm.nih.gov/pubmed/20331325
http://dx.doi.org/10.18553/jmcp.2010.16.3.206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438194/
https://www.ncbi.nlm.nih.gov/pubmed/20331325
http://dx.doi.org/10.18553/jmcp.2010.16.3.206

Ejemplares similares